Building on 25 years of TEVAR experience we’ve combined a proven stent graft with controlled, staged deployment, uniquely designed for trusted conformability and anatomical adaptability.

video thumbnail

We create solutions engineered to perform as promised.

Watch Video (01:00)

Michael D. Dake, M.D.*“Gore has a long history with TEVAR. We look back on 25 years and think of all the milestones. There's been an enduring benefit to patients over a long period of time.”

- Michael D. Dake, M.D.*

Joseph E. Bavaria, M.D.*“They were the first ones to come out with a TEVAR device, and a branch arch device, and a dissection indication. They have a whole series of firsts for us and our patients.”

- Joseph E. Bavaria, M.D.*

Text reads: Because of you, TEVAR Triumphs

From the first FDA approved thoracic device to future development, we are TEVAR.

See all the firsts.

Darren B. Schneider, M.D.*“Gore really helped pioneer these devices and advance the technology and make it applicable to everyday treatment of these patients.”

- Darren B. Schneider, M.D.*

Gustavo Oderich, M.D.*“The first time I used the [GORE® TAG® Thoracic Endoprosthesis ] I was a resident. Fast forward 20 years, what we are doing now, we couldn't even think about it.”

- Gustavo Oderich, M.D.*

Deliberately designed to enable long-term results you can trust and your patients count on.

Download brochure.

* Paid consultant for Gore.

eIFU Symbol

INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Conformable Thoracic Stent Graft is intended for endovascular repair of all lesions of the descending thoracic aorta, including: isolated lesions in patients who have appropriate anatomy, including: adequate iliac/femoral access, aortic inner diameter in the range of 16-42 mm, ≥ 20 mm non-aneurysmal aorta proximal and distal to the lesion; Type B dissections in patients who have appropriate anatomy, including: adequate iliac/femoral access, ≥ 20 mm landing zone proximal to the primary entry tear; proximal extent of the landing zone must not be dissected, diameter at proximal extent of proximal landing zone in the range of 16-42 mm.

CONTRAINDICATIONS: Patients with known sensitivities or allergies to the device materials; patients who have a condition that threatens to infect the graft. Refer to Instructions for Use at for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly


GORE TAG Conformable Thoracic Stent Graft logo